Global Urinary Incontinence Market (2023 Edition) - Analysis By Incontinence Type (Stress, Urge, Mixed, Others), Product Type, End-user, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

Global Urinary Incontinence Market (2023 Edition) - Analysis By Incontinence Type (Stress, Urge, Mixed, Others), Product Type, End-user, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

Executive Summary

Azoth Analytics has released a research report titled “Global Urinary Incontinence Market (2023 Edition)” which provides a complete analysis of the global Urinary Incontinence industry in terms of market segmentation By Product Type (Devices, Disposables, Other Products), Incontinence Type (Stress Incontinence, Urge Incontinence, Mixed Incontinence, Other Incontinence) and By End User (Hospitals, Specialty Clinics, Homecare).

The research is global in nature and covers a detailed analysis of the market in America (U.S., Canada, Rest of Americas), Europe (Germany, U.K, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), and the Middle East and Africa. Additionally, the research report displays data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and strategic recommendations.

The research study also looks at the market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

Urinary Incontinence is a global health issue that affects around 200 million people globally. The disorder may occur at any age due to several factors however it’s largely associated with the elderly population because of the high prevalence of UI in adults over age 65, who are the key end-user demographic of Urinary incontinence products. The Global Urinary Incontinence Market is expected to generate 21.1 billion by the end of 2028, up from USD 14664.64 million in 2021. During the forecast period, 2023-2028, the Global Urinary Incontinence market is expected to expand at a CAGR of 8.12%. Moreover, Urinary Incontinence is twice as prominent in Women than in Men. This is due to the fact that women's reproductive health events, such as pregnancy, delivery, and menopause, alter the bladder, urethra, and other pelvic floor muscles that support these organs. Additionally, Diabetes, Obesity, Chronic lung infections and cough, neurological conditions and prostate disorders are risk factors associated with Urinary incontinence which is consequentially backing the market growth.

Companies are choosing interactive and engaging advertisements to battle social stigmas associated with the disease because people who experience, urinary incontinence are often subjected to stigma and psychological distress. Urinary incontinence is a condition that many individuals find embarrassing or afraid to discuss, which can result in a restraint to the flourishing growth of the market. Among product types, disposables hold the maximum share in the market. The global market for urinary incontinence disposables is expected to grow in the coming years, driven by several factors such as the increasing prevalence of urinary incontinence and the growing demand for convenient and discreet solutions. Adult diapers, pads, and liners are among the most common types of urinary incontinence disposables, providing patients with comfort, confidence, and the ability to maintain their normal activities and routines.

This study also provides the current competition status of some of the leading players in the Global Urinary Incontinence Market including Boston Scientific, Becton Dickinson & Company, Coloplast, Caldera Cook Group Inc., Convatec Group Plc, Medtronic Plc, Teleflex Incorporated, Asahi Kasei Corporation, Berry Global, Cardinal Health Incorporated. The company profiling includes critical information such as a business overview, products and services, key financials, and recent events and developments. Overall, the report provides a detailed overview of the Global Urinary Incontinence Market, which will assist industry consultants, equipment manufacturers, existing players looking for expansion opportunities, new players looking for opportunities, and other stakeholders in aligning their market-centric strategies with current and expected future trends.

Scope of the Report

• The report presents the analysis of the Global Urinary Incontinence Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
• The report analyses the Global Urinary Incontinence Market by Product Type (Devices, Disposables, Other Products) by Value (USD Million).
• The report analyses the Global Urinary Incontinence Market by Incontinence Type (Stress Incontinence, Urge Incontinence, Mixed Incontinence, Other Incontinence).
• The report analyses the Global Urinary Incontinence Market By End User (Hospitals, Specialty Clinics, Homecare).
• The Global Urinary Incontinence Market has been analyzed by region and countries including the Americas (U.S., Canada, Rest of Americas), Europe (Germany, U.K, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), and Middle East and Africa.
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analyzed in the report include Boston Scientific, Becton Dickinson & Company, Coloplast, Caldera Cook Group Inc., Convatec Group Plc, Medtronic Plc, Teleflex Incorporated, Asahi Kasei Corporation, Berry Global, Cardinal Health Incorporated.

Key Target Audience

• Urinary Incontinence Companies
• Pharmaceutical Companies
• Consulting and Advisory Firms
• Government and Regulatory Authorities